Showing results (361-370 of 531) with videos related to
Sort By:
Pageof 54
Genomics|April 7, 1999
Functional characterization of the human PAX3 gene regulatory regionO Okladnova, Y V Syagailo, M Tranitz, et al.Neuroscience Letters|February 19, 1993
Adenosine A1 receptors in human hippocampus: inhibition of [3H]8-cyclopentyl-1,3-dipropylxanthine binding by antagonist drugsJ Deckert, W Berger, K Kleopa, et al.Journal of Neural Transmission. Supplementum|November 7, 2007
Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practiceB Pfuhlmann, M Gerlach, R Burger, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|April 21, 2001
The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated ratsM Gerlach, A Y Xiao, W Kuhn, et al.European Journal of Biochemistry|June 24, 2000
Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptideC Loske, A Gerdemann, W Schepl, et al.Neuroscience Letters|March 3, 1995
Regional differences in the interaction of the excitotoxins domoate and L-beta-oxalyl-amino-alanine with [3H]kainate binding sites in human hippocampusG Künig, J Hartmann, F Krause, et al.Brain Research|October 10, 1994
Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical studyE Oestreicher, G J Sengstock, P Riederer, et al.Biological Psychiatry|July 1, 1994
Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patientsJ Kornhuber, K W Lange, P Kruzik, et al.Neurotoxicology and Teratology|August 30, 2002
Influence of neuromelanin on oxidative pathways within the human substantia nigraK L Double, D Ben-Shachar, M B H Youdim, et al.Journal of Neurochemistry|October 26, 2001
Brain iron pathways and their relevance to Parkinson's diseaseD Berg, M Gerlach, M B Youdim, et al.Pageof 54